Northland Capital Partners Increases CAS Medical Systems Price Target to $3.50 (CASM)
Northland Capital Partners hoisted their target price on shares of CAS Medical Systems (NASDAQ:CASM) from $3.00 to $3.50 in a research note issued on Thursday, AnalystRatings.NET reports. The firm currently has an “outperform” rating on the stock. Northland Capital Partners’ price objective points to a potential upside of 68.27% from the company’s current price.
Separately, analysts at Northland Securities initiated coverage on shares of CAS Medical Systems in a research note to investors on Monday, December 2nd. They set an “outperform” rating on the stock.
CAS Medical Systems (NASDAQ:CASM) traded down 0.96% on Thursday, hitting $2.06. The stock had a trading volume of 93,915 shares. CAS Medical Systems has a 52-week low of $1.211 and a 52-week high of $2.376. The stock’s 50-day moving average is $1.74 and its 200-day moving average is $1.53. The company’s market cap is $38.5 million.
CAS Medical Systems (NASDAQ:CASM) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.19) earnings per share for the quarter. The company had revenue of $5.40 million for the quarter, compared to the consensus estimate of $6.10 million. Analysts expect that CAS Medical Systems will post $-0.54 EPS for the current fiscal year.
CAS Medical Systems, Inc (NASDAQ:CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.